United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 359.58 USD -0.16% Market Closed
Market Cap: 16.1B USD
Have any thoughts about
United Therapeutics Corp?
Write Note

Intrinsic Value

The intrinsic value of one UTHR stock under the Base Case scenario is 375 USD. Compared to the current market price of 359.58 USD, United Therapeutics Corp is Undervalued by 4%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

UTHR Intrinsic Value
375 USD
Undervaluation 4%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
United Therapeutics Corp

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
UTHR
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for UTHR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about UTHR?
Bearish
Neutral
Bullish

Fundamental Analysis

359.58 USD
-0.16%
-0.16%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

United Therapeutics Corp
US
Biotechnology
Market Cap
16B USD
IPO
Jun 17, 1999
Employees
965
United States of America
Market Cap
16B USD
Industry
Biotechnology
IPO
Jun 17, 1999
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about United Therapeutics Corp

Provide an overview of the primary business activities
of United Therapeutics Corp.

What unique competitive advantages
does United Therapeutics Corp hold over its rivals?

What risks and challenges
does United Therapeutics Corp face in the near future?

Has there been any significant insider trading activity
in United Therapeutics Corp recently?

Summarize the latest earnings call
of United Therapeutics Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for United Therapeutics Corp.

Provide P/S
for United Therapeutics Corp.

Provide P/E
for United Therapeutics Corp.

Provide P/OCF
for United Therapeutics Corp.

Provide P/FCFE
for United Therapeutics Corp.

Provide P/B
for United Therapeutics Corp.

Provide EV/S
for United Therapeutics Corp.

Provide EV/GP
for United Therapeutics Corp.

Provide EV/EBITDA
for United Therapeutics Corp.

Provide EV/EBIT
for United Therapeutics Corp.

Provide EV/OCF
for United Therapeutics Corp.

Provide EV/FCFF
for United Therapeutics Corp.

Provide EV/IC
for United Therapeutics Corp.

Show me price targets
for United Therapeutics Corp made by professional analysts.

What are the Revenue projections
for United Therapeutics Corp?

How accurate were the past Revenue estimates
for United Therapeutics Corp?

What are the Net Income projections
for United Therapeutics Corp?

How accurate were the past Net Income estimates
for United Therapeutics Corp?

What are the EPS projections
for United Therapeutics Corp?

How accurate were the past EPS estimates
for United Therapeutics Corp?

What are the EBIT projections
for United Therapeutics Corp?

How accurate were the past EBIT estimates
for United Therapeutics Corp?

Compare the revenue forecasts
for United Therapeutics Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of United Therapeutics Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of United Therapeutics Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of United Therapeutics Corp compared to its peers.

Compare the P/E ratios
of United Therapeutics Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing United Therapeutics Corp with its peers.

Analyze the financial leverage
of United Therapeutics Corp compared to its main competitors.

Show all profitability ratios
for United Therapeutics Corp.

Provide ROE
for United Therapeutics Corp.

Provide ROA
for United Therapeutics Corp.

Provide ROIC
for United Therapeutics Corp.

Provide ROCE
for United Therapeutics Corp.

Provide Gross Margin
for United Therapeutics Corp.

Provide Operating Margin
for United Therapeutics Corp.

Provide Net Margin
for United Therapeutics Corp.

Provide FCF Margin
for United Therapeutics Corp.

Show all solvency ratios
for United Therapeutics Corp.

Provide D/E Ratio
for United Therapeutics Corp.

Provide D/A Ratio
for United Therapeutics Corp.

Provide Interest Coverage Ratio
for United Therapeutics Corp.

Provide Altman Z-Score Ratio
for United Therapeutics Corp.

Provide Quick Ratio
for United Therapeutics Corp.

Provide Current Ratio
for United Therapeutics Corp.

Provide Cash Ratio
for United Therapeutics Corp.

What is the historical Revenue growth
over the last 5 years for United Therapeutics Corp?

What is the historical Net Income growth
over the last 5 years for United Therapeutics Corp?

What is the current Free Cash Flow
of United Therapeutics Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for United Therapeutics Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
United Therapeutics Corp

Current Assets 4B
Cash & Short-Term Investments 3.3B
Receivables 341.8m
Other Current Assets 332.1m
Non-Current Assets 3.1B
Long-Term Investments 1.3B
PP&E 1.2B
Intangibles 112.1m
Other Non-Current Assets 574.5m
Current Liabilities 873.4m
Accounts Payable 363.9m
Other Current Liabilities 509.5m
Non-Current Liabilities 148.8m
Other Non-Current Liabilities 148.8m
Efficiency

Earnings Waterfall
United Therapeutics Corp

Revenue
2.8B USD
Cost of Revenue
-304.8m USD
Gross Profit
2.5B USD
Operating Expenses
-1.1B USD
Operating Income
1.3B USD
Other Expenses
-237.2m USD
Net Income
1.1B USD

Free Cash Flow Analysis
United Therapeutics Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

UTHR Profitability Score
Profitability Due Diligence

United Therapeutics Corp's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

75/100
Profitability
Score

United Therapeutics Corp's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

UTHR Solvency Score
Solvency Due Diligence

United Therapeutics Corp's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
93/100
Solvency
Score

United Therapeutics Corp's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

UTHR Price Targets Summary
United Therapeutics Corp

Wall Street analysts forecast UTHR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UTHR is 401.61 USD with a low forecast of 305.02 USD and a high forecast of 630 USD.

Lowest
Price Target
305.02 USD
15% Downside
Average
Price Target
401.61 USD
12% Upside
Highest
Price Target
630 USD
75% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for UTHR?

Click here to dive deeper.

Dividends

United Therapeutics Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for UTHR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

UTHR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

UTHR News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one UTHR stock?

The intrinsic value of one UTHR stock under the Base Case scenario is 375 USD.

Is UTHR stock undervalued or overvalued?

Compared to the current market price of 359.58 USD, United Therapeutics Corp is Undervalued by 4%.

Back to Top